Find clinical trials for Ovarian Cancer in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Seattle, WA, USA:
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...
Phase 2
Tacoma, Washington, United States and 25 other locations
(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...
Phase 1
Seattle, Washington, United States and 1 other location
This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...
Phase 1
Seattle, Washington, United States and 9 other locations
of 2X-121 as single agent therapy in a 28-days cycle in advanced ovarian cancer patients. 2X-121 will be supplied for oral administ...
Phase 2
Seattle, Washington, United States and 4 other locations
within each cohort-specific supplement in participants with ovarian, fallopian tube, or primary peritoneal cancer. Cohort A (single ...
Phase 1, Phase 2
Seattle, Washington, United States and 24 other locations
outcome of ADP A2M4CD8 as monotherapy and in combination treatment with nivolumab in human leukocyte antigen (HLA) A2+ subjects with recurrent ovarian...
Phase 2
Seattle, Washington, United States and 28 other locations
maintenance treatment in participants with advanced (stage IIIB-IV) ovarian cancer, fallopian tube cancer, or primary peri...
Phase 2
Seattle, Washington, United States and 27 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Seattle, Washington, United States and 189 other locations
The primary objective is to evaluate in participants with high-grade serous ovarian cancer (HGSOC), whether the reduction from base...
Phase 2
Seattle, Washington, United States and 44 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Seattle, Washington, United States and 194 other locations
Clinical trials
Research sites
Resources
Legal